Hematologic Malignancy
T-Cell Large Granular Lymphocyte Leukemia
CI-CAN-00004059LGLLExplore in graph →
Hematologic8 active trials1 evidence items
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00004059LGLLExplore in graph →
Clinical trials
58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (14)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04453345 | TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL | unknown | Phase 2 / Phase 3 | 42 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Jul 1, 2020 | clinicaltrials |
Data updated 22 days agoSource updated Jul 1, 2020source: clinicaltrials